This Journal feature begins with a case vignette that includes a therapeutic recommendation. A discussion of the clinical problem and the mechanism of benefit of this form of therapy follows. Major ...
Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...
Objective Hydroxychloroquine (HCQ) is a cornerstone therapy for SLE, reducing flares, organ damage and mortality. However, ...
Systemic lupus erythematosus (SLE) is an autoimmune disease where the immune system attacks the body’s own tissues. It’s the most common form of lupus and affects over 204,000 Americans. Common ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results